Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-25

Clinical Trial Update: LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV) [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating chemotherapy plus rituximab and highly active antiretroviral therapy for patients with diffuse large B-cell lymphoma and HIV has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HAART (Highly Active Antiretroviral Therapy) (Highly Active Antiretroviral Therapy)
  • Rituximab (rituximab)

Snippet

Sponsor: PETHEMA Foundation | Conditions: HIV Infections, Diffuse Large B Cell Lymphoma | Phase 4 | Status: COMPLETED